August 25, 2020
Acquisition allows Pace Life Sciences to serve pharmaceutical and biopharmaceutical companies from early-stage product development through phase II clinical trial material manufacturing.

Acquisition allows Pace Life Sciences to serve pharmaceutical and biopharmaceutical companies from early-stage product development through phase II clinical trial material manufacturing.
Judy Morgan of Pace and NEMC organizer Jerry Parr to deliver a keynote on the history of the EPA August 6th.